Followers | 217 |
Posts | 13067 |
Boards Moderated | 14 |
Alias Born | 06/20/2022 |
Monday, November 18, 2024 8:15:27 AM
Recent HCWB News
- HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025 • GlobeNewswire Inc. • 01/15/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 01:30:10 PM
- HCW Biologics Inc. Received NASDAQ Staff Determination Letter • GlobeNewswire Inc. • 12/23/2024 01:10:13 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 12/05/2024 09:37:20 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/22/2024 09:53:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2024 09:45:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2024 09:42:31 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 11/20/2024 05:54:40 PM
- HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules • GlobeNewswire Inc. • 11/19/2024 02:27:48 AM
- HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate • GlobeNewswire Inc. • 11/18/2024 12:00:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2024 12:00:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 10:14:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 10:13:01 PM
- HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 11/14/2024 09:40:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 09:25:48 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/23/2024 08:35:07 PM
- HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction • GlobeNewswire Inc. • 08/23/2024 08:30:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:45:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:40:08 PM
- HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 08/14/2024 08:35:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:35:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 11:00:11 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 08:57:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:33:01 PM
FEATURED LaFleur Minerals Provides Updates on Exploration at Swanson Gold Deposit and Plans to Restart of Beacon Gold Mill • Jan 27, 2025 9:47 AM
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform • AVAI • Jan 27, 2025 8:00 AM
$BEOLF: Will Beyond Oil Skyrocket Monday? Multi-Million Dollar U.S. Deal Backed by Trump Advisor Aiming to Implement them as a US Standard • RKLB • Jan 27, 2025 7:10 AM
Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing • BLO • Jan 24, 2025 8:49 AM
UC Asset Announces Plan of Secondary Public Offering via Reg A • UCASU • Jan 23, 2025 9:30 AM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM